In a separate methylation study, Tompa and colleagues found a high frequency of methylation for genes in the IL-7 signaling pathway—a critical pathway for cell survival and antitumor responses—with additional correlations found between IL-7 pathway hypermutation and GBM recurrence [36]. The gene discussed is IL7; the disease is glioblastoma.